Literature DB >> 1543349

Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy.

J Kira1, Y Itoyama, Y Koyanagi, J Tateishi, M Kishikawa, S Akizuki, I Kobayashi, N Toki, K Sueishi, H Sato.   

Abstract

The polymerase chain reaction (PCR) method was used to determine the presence and amount of human T lymphotropic virus type I (HTLV-I) proviral DNA in central nervous system (CNS) tissue obtained at autopsy from 6 patients with HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP), 1 patient with adult T-cell leukemia (ATL) and CNS infiltration of leukemic cells, and 9 control subjects with other neurological disorders. HTLV-I pX and env but not pol DNA were detected in CNS tissue from 5 of 6 patients with HAM/TSP. The ATL samples were positive for pX, env, and pol DNA by PCR. None of the control samples was consistently positive for HTLV-I by PCR, but all showed positive bands on beta-globin PCR. Quantitative PCR combined with histological studies showed no correlation between HTLV-I proviral DNA amounts and extent of perivascular mononuclear cell infiltration in the HAM/TSP CNS. Also, the amounts of pX and probably env DNA were greater in the HAM/TSP samples than in the ATL sample, although the extent of mononuclear cell infiltration was far less in the HAM/TSP samples than in the ATL sample. Therefore, in addition to infiltrating mononuclear cells, constituent cells of the CNS may harbor the HTLV-I genome, at least in the pX and env regions, in patients with HAM/TSP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1543349     DOI: 10.1002/ana.410310108

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  22 in total

Review 1.  HTLV-1 and HIV infections of the central nervous system in tropical areas.

Authors:  P Cabre; D Smadja; A Cabié; C R Newton
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-05       Impact factor: 10.154

2.  Physical and functional interaction between the human T-cell lymphotropic virus type 1 Tax1 protein and the CCAAT binding protein NF-Y.

Authors:  C A Pise-Masison; J Dittmer; K E Clemens; J N Brady
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

3.  Tax interacts with P-TEFb in a novel manner to stimulate human T-lymphotropic virus type 1 transcription.

Authors:  Meisheng Zhou; Hanxin Lu; Hyeon Park; Jaime Wilson-Chiru; Rebecca Linton; John N Brady
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM).

Authors:  A Yoshioka; G Hirose; Y Ueda; Y Nishimura; K Sakai
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

5.  Do T cells cause HTLV-1-associated disease?: a taxing problem.

Authors:  S Daenke; C R Bangham
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

Review 6.  The myeloneuropathies of Jamaica.

Authors:  O St Clair Morgan
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

Review 7.  Genetic control and dynamics of the cellular immune response to the human T-cell leukaemia virus, HTLV-I.

Authors:  C R Bangham; S E Hall; K J Jeffery; A M Vine; A Witkover; M A Nowak; D Wodarz; K Usuku; M Osame
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-04-29       Impact factor: 6.237

8.  Identification of human T-cell lymphotropic virus type I 21-base-pair repeat-specific and glial cell-specific DNA-protein complexes.

Authors:  M Tillmann; R Wessner; B Wigdahl
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations.

Authors:  E Wu; D W Dickson; S Jacobson; C S Raine
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  The presence of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.

Authors:  J Kira
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.